Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-01

Clinical Trial Update: REQUIP RLS Post Marketing Surveillance

View source ↗

Summary

Post-marketing surveillance study update for REQUIP in restless legs syndrome; completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REQUIP (ropinirole hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome | Status: COMPLETED | Results posted: 2011-04-01